Shared on 01 May 25
Fair value Decreased 9.83%Domestic Chronic Focus And API Capacity Will Foster Global Opportunities
Shared on 23 Apr 25
Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 0.46%Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 0.37%Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 2.32%Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 11%Expansion Into Flexicare And Dermatology Will Strengthen Future Performance
AnalystConsensusTarget has decreased future PE multiple from 39.0x to 33.5x.